NF-&kgr;B Activating Scaffold Proteins as Signaling Molecules and Putative Therapeutic Targets

By  

Current Medicinal Chemistry, Vol. 10, Iss. 7, 2003-04 ,pp. : 593-602

Bentham Science Publishers

Access to resources Recommend Favorite

Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides

By Sun Li-Xin   Lin Zhi-Bin   Duan Xin-Suo   Lu Jie   Ge Zhi-Hua   Li Xue-Fei   Li Xue-Jun   Li Min   Xing En-Hong   Song You-Xin   Jia Jing   Li Wei-Dong  

Journal of Drug Targeting, Vol. 20, Iss. 7, 2012-08 ,pp. : 582-592

Informa Healthcare

Access to resources Recommend Favorite

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

New therapeutic targets in immune disorders: ItpkB, Orai1 and UNC93B

By Huang Yina H   Hoebe Kasper   Sauer Karsten  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 391-413

Informa Healthcare

Access to resources Recommend Favorite

β2-adrenergic Receptor Stimulation-induced Immunosuppressive Effects Possibly through Down-regulation of Co-stimulatory Molecules, ICAM-1, CD40 and CD14 on Monocytes

By Kuroki K   Takahashi HK   Iwagaki H   Murakami T   Kuinose M   Hamanaka S   Minami K   Nishibori M   Tanaka N   Tanemoto K  

The Journal of International Medical Research, Vol. 32, Iss. 5, 2004-09 ,pp. : 465-483

Field House Publishing

Access to resources Recommend Favorite